Loading...
XWAR
PCR
Market cap361mUSD
Dec 05, Last price  
66.00PLN
1D
-0.45%
1Q
-4.35%
Jan 2017
-2.65%
IPO
91.97%
Name

PCC Rokita SA

Chart & Performance

D1W1MN
XWAR:PCR chart
P/E
9.16
P/S
0.67
EPS
7.20
Div Yield, %
20.30%
Shrs. gr., 5y
Rev. gr., 5y
5.47%
Revenues
1.95b
-18.46%
1,056,888,5541,101,188,3591,092,942,9751,048,749,2741,107,195,0001,285,892,0001,489,803,0001,491,911,0001,475,850,0002,203,306,0003,142,712,0002,388,191,0001,947,364,000
Net income
143m
-46.59%
265,050,19658,280,06071,205,55784,752,085202,715,000182,346,000226,771,00093,265,000117,390,000417,304,000675,056,000267,840,000143,043,000
CFO
274m
-46.55%
111,676,052103,756,784164,551,601149,178,170262,876,000204,101,000286,874,000310,064,000365,574,000529,937,000792,325,000512,104,000273,745,000
Dividend
May 24, 20246.7 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PCC Rokita SA manufactures and distributes chemical products in Poland and internationally. The company offers chloralkali, raw materials, and intermediates; polyurethanes; specialty products; and surfactants products, as well as polyols, naphthalene, and phosphorus derivatives. It serves adhesives, agrochemicals, building and construction, case, chemical reagents, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and metalworking fluids, base oils, metallurgical, mining and drilling, oilfield, packaging, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, vehicle cleaning and care, and water and wastewater treatment industries. The company is based in Brzeg Dolny, Poland. PCC Rokita SA is a subsidiary of PCC SE.
IPO date
Jun 25, 2014
Employees
1,822
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT